March 03, 2015 12:22 PM ET


Company Overview of Kolltan Pharmaceuticals, Inc.

Key Executives for Kolltan Pharmaceuticals, Inc.

NameBoard RelationshipsTitleAge
Gerald McMahon Ph.D.27 RelationshipsChief Executive Officer, President and Director59
Arthur G. Altschul Jr.37 RelationshipsCo-Founder and Chairman of the Board49
Joseph P. Schlessinger Ph.D.74 RelationshipsCo-Founder, Chairman of Scientific Advisory Board, Chief Scientist and Director69
Jane Pritchett V. Henderson 8 RelationshipsChief Financial & Business Officer and Senior Vice President48
Theresa M. Lavallee Ph.D.No RelationshipsSenior Vice President of Translational Medicine & Product Development48
View More Key Executives

Kolltan Pharmaceuticals, Inc. Board Members*

NameBoard RelationshipsPrimary CompanyAge
Arthur G. Altschul Jr. 37 RelationshipsKolltan Pharmaceuticals, Inc.49
Gerald McMahon Ph.D. 27 RelationshipsKolltan Pharmaceuticals, Inc.59
Axel Bolte MSc., M.B.A. 41 RelationshipsHBM Partners Ltd.42
Joseph P. Schlessinger Ph.D. 74 RelationshipsKolltan Pharmaceuticals, Inc.69
K. Peter Hirth Ph.D. 83 RelationshipsTrovaGene, Inc.62
View All Board Members

Kolltan Pharmaceuticals, Inc. Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
Advisory Board Ph.D.Joseph P. Schlessinger74 Relationships8 Executives
View Committee Details
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


  Industry Range
Not meaningful
Total Short Term Compensation
Not meaningful
Total Value of Options$400.0K
Compensation as of Fiscal Year 2013
Kolltan Pharmaceuticals, Inc. CEO Compensation
Industry Average


Eveready Industries India Limited Announces P H Ravikumar Ceased to Be Independent Director
March 02, 2015 9:29 AM ET
SCA Announces Executive Changes
March 02, 2015 7:07 AM ET
SCA Appoints Linda Nyberg as Vice President of Media Relations and Online Communications
February 26, 2015 12:00 AM ET
Hipolin Limited Announces Management Appointments
February 23, 2015 10:19 AM ET
Harbinger Group Inc. Appoints Curtis Glovier as Class II Director
February 20, 2015 10:05 PM ET

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Kolltan Pharmaceuticals, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at